|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis CE, Lin CC, Mariotto AB, et al:
Cancer treatment and survivorship statistics, 2014. CA Cancer J
Clin. 64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eccles SA and Welch DR: Metastasis: recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar :
|
|
6
|
McCarthy JJ: MicroRNA-206: the skeletal
muscle-specific myomiR. Biochim Biophys Acta. 1779:682–691. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kondo N, Toyama T, Sugiura H, Fujii Y and
Yamashita H: miR-206 Expression is down-regulated in estrogen
receptor alpha-positive human breast cancer. Cancer Res.
68:5004–5008. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Taulli R, Bersani F, Foglizzo V, et al:
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma
growth in xenotransplanted mice by promoting myogenic
differentiation. J Clin Invest. 119:2366–2378. 2009.PubMed/NCBI
|
|
9
|
Zhou L, Chen J, Li Z, et al: Integrated
profiling of microRNAs and mRNAs: microRNAs located on Xq27.3
associate with clear cell renal cell carcinoma. PLoS One.
5:e152242010. View Article : Google Scholar
|
|
10
|
Wang X, Ling C, Bai Y and Zhao J:
MicroRNA-206 is associated with invasion and metastasis of lung
cancer. Anat Rec. 294:88–92. 2011. View
Article : Google Scholar
|
|
11
|
Zhang T, Liu M, Wang C, Lin C, Sun Y and
Jin D: Down-regulation of MiR-206 promotes proliferation and
invasion of laryngeal cancer by regulating VEGF expression.
Anticancer Res. 31:3859–3863. 2011.PubMed/NCBI
|
|
12
|
Chen X, Yan Q, Li S, et al: Expression of
the tumor suppressor miR-206 is associated with cellular
proliferative inhibition and impairs invasion in ERα-positive
endometrioid adenocarcinoma. Cancer Lett. 314:41–53. 2012.
View Article : Google Scholar
|
|
13
|
Vickers MM, Bar J, Gorn-Hondermann I, et
al: Stage-dependent differential expression of microRNAs in
colorectal cancer: potential role as markers of metastatic disease.
Clin Exp Metastasis. 29:123–132. 2012. View Article : Google Scholar
|
|
14
|
Zhang L, Liu X, Jin H, et al: miR-206
inhibits gastric cancer proliferation in part by repressing
cyclinD2. Cancer Lett. 332:94–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Georgantas RW III, Streicher K, Luo X, et
al: MicroRNA-206 induces G1 arrest in melanoma by inhibition of
CDK4 and Cyclin D. Pigment Cell Melanoma Res. 27:275–286. 2014.
View Article : Google Scholar
|
|
16
|
Missiaglia E, Shepherd CJ, Patel S, et al:
MicroRNA-206 expression levels correlate with clinical behaviour of
rhabdomyosarcomas. Br J Cancer. 102:1769–1777. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Adams BD, Furneaux H and White BA: The
micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen
receptor-alpha (ERalpha) and represses ERalpha messenger RNA and
protein expression in breast cancer cell lines. Mol Endocrinol.
21:1132–1147. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yan D, da Dong XE, Chen X, et al:
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma
development. J Biol Chem. 284:29596–29604. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song G, Zhang Y and Wang L: MicroRNA-206
targets notch3, activates apoptosis, and inhibits tumor cell
migration and focus formation. J Biol Chem. 284:31921–31927. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lardelli M, Dahlstrand J and Lendahl U:
The novel Notch homologue mouse Notch 3 lacks specific epidermal
growth factor-repeats and is expressed in proliferating
neuroepithelium. Mech Dev. 46:123–136. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Serafin V, Persano L, Moserle L, et al:
Notch3 signalling promotes tumour growth in colorectal cancer. J
Pathol. 224:448–460. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gagan J, Dey BK, Layer R, Yan Z and Dutta
A: Notch3 and Mef2c proteins are mutually antagonistic via Mkp1
protein and miR-1/206 microRNAs in differentiating myoblasts. J
Biol Chem. 287:40360–40370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang WX, Wilfred BR, Baldwin DA, et al:
Focus on RNA isolation: obtaining RNA for microRNA (miRNA)
expression profiling analyses of neural tissue. Biochim Biophys
Acta. 1779:749–757. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mu Y, Zhou H, Li W, Hu L and Zhang Y:
Evaluation of RNA quality in fixed and unembedded mouse embryos by
different methods. Exp Mol Pathol. 95:206–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Guo R, Wu Q, Liu F and Wang Y: Description
of the CD133+ subpopulation of the human ovarian cancer cell line
OVCAR3. Oncol Rep. 25:141–146. 2011.
|
|
27
|
Tavazoie SF, Alarcon C, Oskarsson T, et
al: Endogenous human microRNAs that suppress breast cancer
metastasis. Nature. 451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bandres E, Cubedo E, Agirre X, et al:
Identification by Real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cummins JM, He Y, Leary RJ, et al: The
colorectal microRNAome. Proc Natl Acad Sci USA. 103:3687–3692.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Monzo M, Navarro A, Bandres E, et al:
Overlapping expression of microRNAs in human embryonic colon and
colorectal cancer. Cell Res. 18:823–833. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ozawa T, Kazama S, Akiyoshi T, et al:
Nuclear Notch3 expression is associated with tumor recurrence in
patients with stage II and III colorectal cancer. Ann Surg Oncol.
21:2650–2658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee SH, Jeong EG and Yoo NJ: Mutational
analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and
acute leukemias. APMIS. 115:1357–1363. 2007. View Article : Google Scholar
|
|
33
|
Zhou L, Zhang N, Song W, et al: The
significance of Notch1 compared with Notch3 in high metastasis and
poor overall survival in hepatocellular carcinoma. PLoS One.
8:e573822013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu W, Xu C, Wan H, et al: MicroRNA-206
overexpression promotes apoptosis, induces cell cycle arrest and
inhibits the migration of human hepatocellular carcinoma HepG2
cells. Int J Mol Med. 34:420–428. 2014.PubMed/NCBI
|
|
35
|
Anderson C, Catoe H and Werner R: MIR-206
regulates connexin43 expression during skeletal muscle development.
Nucleic Acids Res. 34:5863–5871. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hufbauer M, Lazic D, Reinartz M, Akgul B,
Pfister H and Weissenborn SJ: Skin tumor formation in human
papillomavirus 8 transgenic mice is associated with a deregulation
of oncogenic miRNAs and their tumor suppressive targets. J Dermatol
Sci. 64:7–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nohata N, Hanazawa T, Enokida H and Seki
N: microRNA-1/133a and microRNA-206/133b clusters: dysregulation
and functional roles in human cancers. Oncotarget. 3:9–21.
2012.PubMed/NCBI
|
|
38
|
Liu H, Cao YD, Ye WX and Sun YY: Effect of
microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in
MDA-MB-231 cells. Tumori. 96:751–755. 2010.
|
|
39
|
Domenga V, Fardoux P, Lacombe P, et al:
Notch3 is required for arterial identity and maturation of vascular
smooth muscle cells. Genes Dev. 18:2730–2735. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang W, Prince CZ, Mou Y and Pollman MJ:
Notch3 signaling in vascular smooth muscle cells induces c-FLIP
expression via ERK/MAPK activation. Resistance to Fas
ligand-induced apoptosis. J Biol Chem. 277:21723–21729. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang T, Holt CM, Xu C, et al: Notch3
activation modulates cell growth behaviour and cross-talk to
Wnt/TCF signalling pathway. Cell Signal. 19:2458–2467. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zeng ZS, Cohen AM and Guillem JG: Loss of
basement membrane type IV collagen is associated with increased
expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during
human colorectal tumorigenesis. Carcinogenesis. 20:749–755. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tran NL, Adams DG, Vaillancourt RR and
Heimark RL: Signal transduction from N-cadherin increases Bcl-2.
Regulation of the phosphatidylinositol 3-kinase/Akt pathway by
homophilic adhesion and actin cytoskeletal organization. J Biol
Chem. 277:32905–32914. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tran NL, Nagle RB, Cress AE and Heimark
RL: N-Cadherin expression in human prostate carcinoma cell lines.
An epithelial-mesenchymal transformation mediating adhesion with
stromal cells. Am J Pathol. 155:787–798. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang H, Wang HS, Zhou BH, et al:
Epithelial-mesenchymal transition (EMT) induced by TNF-α requires
AKT/GSK-3β-mediated stabilization of snail in colorectal cancer.
PLoS One. 8:e566642013. View Article : Google Scholar
|
|
46
|
Tang F, Hajkova P, Barton SC, et al:
MicroRNA expression profiling of single whole embryonic stem cells.
Nucleic Acids Res. 34:e92006. View Article : Google Scholar : PubMed/NCBI
|
